BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2000
View Archived Issues
Chiron and Norwegian National Institutes of Public Health formalize meningitis agreement
Read More
Pivotal trials of Cangene human growth hormone begin
Read More
Genmab completes financing round; company to accelerate human antibody therapeutics development
Read More
Millennium submits IND application for ulcerative colitis treatment to FDA
Read More
Ibis Therapeutics and Agouron embark on drug discovery collaboration
Read More
Gilead begins another multinational phase III trial of once-daily oral anti-HIV drug
Read More
MorphoSys licenses HuCAL technology to Eos Biotechnology
Read More
New NHLBI study to identify best treatment for mild persistent asthma
Read More
Nexell obtains exclusive license to Diaclone antibody portfolio
Read More
Serono and PowderJect achieve development milestone
Read More
Nastech reports pilot phase I trial results for new formulation of butorphanol
Read More
Interneuron licenses rights to PRO-2000
Read More
JTT-501 improves insulin resistance and exerts antidiabetic effects with less weight gain
Read More
Improvement in insulin sensitivity demonstrated for WAY-123783 in model of severe insulin resistance
Read More
Modified CNTF improves glucose tolerance and insulin-dependent signaling in db/db mice
Read More
Phase II trial of Genentech's anti-CD18 antibody fails to meet primary objectives
Read More
Data from primate and early clinical studies on oral DPP-IV inhibitor presented at ADA meeting
Read More
Seretide MDI approved in the U.K. for asthma Rx
Read More
Roche seeks approval for Tamiflu pediatric indication
Read More
Intermittent neridronate effective in bone disorders and rheumatoid arthritis
Read More
Vitamin D3 derivatives synthesized at Teijin, particularly useful for airways diseases
Read More
New PDE4/TNF inhibitors with superior physicochemical and pharmacokinetic profile
Read More
R.J. Reynolds presents new amine nicotinic acetylcholine receptor agonists
Read More
Potent and selective COX-2 inhibitors from Chugai
Read More
Immunosuppressive 2-acylquinolines developed by Japanese lab
Read More
Neurocrine Biosciences patents new CRF antagonists
Read More
LHRH (GnRH) analogue useful for osteoporosis and other bone disorders
Read More
Aventis describes production and activity of new antibiotic
Read More
Novel Roche compounds for MMP-related diseases
Read More